Results 171 to 180 of about 30,774 (229)

A formulation science perspective applied to combination vaccines: particles-based multiplex immunoassays for improved antigens characterization and rational design of adjuvants for tailored immunity to acellular pertussis vaccines

, 2015
Valentina Agnolon
openalex   +1 more source

The immune response of mice to phiX174. The potentiation of B-cell immunity and the suppression of T-cell help by pertussis vaccine.

, 1975
D. W. Dresser, T. Tao
openalex   +1 more source

Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.

Lancet Glob Health
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, Cantrell L, Lesne E, Gorringe A, Halkerston R, Mcstraw N, Dixon L, Hunter OF, Heath PT, Imede E, Kyohere M, Musoke P, Nakimuli A, Sekikubo M, Taylor S, Tusubira V, Sadarangani M, Le Doare K.   +22 more
europepmc   +1 more source

Safety and Immunogenicity of an Acellular Pertussis Vaccine Containing Genetically-Detoxified Pertussis Toxin Administered to Pregnant Women Living with and Without HIV and Their New-Borns: A Randomised Controlled Trial in Uganda

Eve Nakabembe, Melanie Greenland, Kyle Amaral, Bahaa Abu Raya, Alexander Amone, E. Lesné, Olivia F. Hunter, R. HALKERSTON, Nikki Mcstraw, Louisa Dixon, Liberty Cantrell, Andrew Gorringe, Paul T. Heath, Esther Imede, Mary Kyohere, Philippa Musoke, Annettee Nakimuli, Valerie Tusubira, Musa Sekikubo, Stephen Taylor, Manish Sadarangani, Kirsty Le Doaré   +21 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pertussis vaccines

Current Opinion in Pediatrics, 2022
Purpose of review Pertussis is a vaccine preventable cough illness. It can be controlled by universal pertussis vaccination. Recent findings Pertussis cases and deaths in children are at a record low number.
James D, Cherry, Saba, Doustmohammadi
openaire   +2 more sources

Pertussis Vaccines

Pediatric Clinics of North America, 1990
Concern over adverse reactions temporally associated with whole cell pertussis vaccine and advances in the understanding of the Bordetella pertussis organism have led to a new generation of more purified acellular vaccines. The biology of the pertussis organism, epidemiology of disease, vaccine development over the decades, and vaccine efficacy and ...
K M, Edwards, D T, Karzon
openaire   +2 more sources

Acellular pertussis vaccines

Current Problems in Pediatrics, 2000
Although whole-cell pertussis vaccines have been highly effective in preventing whooping cough, their common and burdensome adverse reactions have spurred the development of safer alternatives. Seven acellular vaccines are licensed in one or more countries; four have been licensed thus far in the United States, and more may follow.
M R, Schleiss, K, Dahl
openaire   +4 more sources

Pertussis vaccine controversies and acellular pertussis vaccine

The Indian Journal of Pediatrics, 2003
Pertussis still continues to cause significant morbidity and mortality worldwide. Because of the high reactogenicity of whole cell pertussis vaccine, it had evoked public controversy in several countries. In 1970 Japan abandoned use of whole cell pertussis vaccine and mounted efforts to develop better vaccine.
Raju C, Shah, Anuj R, Shah
openaire   +2 more sources

Improving pertussis vaccination

Human Vaccines, 2009
Despite a high vaccine coverage, pertussis has re-emerged and has become the most prevalent vaccine preventable disease in developed countries. The re-emergence of pertussis has been attributed to various factors, including increased awareness, improved diagnostics, suboptimal vaccines, waning vaccine-induced immunity and pathogen adaptation.
Guy A M, Berbers, Sabine C, de Greeff, Frits R, Mooi   +2 more
openaire   +2 more sources